Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.1.79 (
hormone-sensitive lipase
)
2,163
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In H295R human adrenocortical cells, ACTH rapidly activates ceramide (Cer) and sphingosine (SPH) turnover with a concomitant increase in SPH-1-phosphate secretion. These bioactive lipids modulate adrenocortical steroidogenesis, primarily by acting as second messengers in the protein kinase A/cAMP-dependent pathway. Acid ceramidase (
ASAH1
) directly regulates the intracellular balance of Cer, SPH, and SPH-1-phosphate by catalyzing the hydrolysis of Cer into SPH. ACTH/cAMP signaling stimulates
ASAH1
transcription and activity, supporting a role for this enzyme in glucocorticoid production. Here, the role of
ASAH1
in regulating steroidogenic capacity was examined using a tetracycline-inducible
ASAH1
short hairpin RNA H295R human adrenocortical stable cell line. We show that
ASAH1
suppression increases the transcription of multiple steroidogenic genes, including Cytochrome P450 monooxygenase (CYP)17A1, CYP11B1/2, CYP21A2, steroidogenic acute regulatory protein,
hormone-sensitive lipase
, 18-kDa translocator protein, and the melanocortin-2 receptor. Induced gene expression positively correlated with enhanced histone H3 acetylation at target promoters. Repression of
ASAH1
expression also induced the expression of members of the nuclear receptor nuclear receptor subfamily 4 (NR4A) family while concomitantly suppressing the expression of dosage-sensitive sex reversal, adrenal hypoplasia critical region, on chromosome X, gene 1.
ASAH1
knockdown altered the expression of genes involved in sphingolipid metabolism and changed the cellular amounts of distinct sphingolipid species. Finally,
ASAH1
silencing increased basal and cAMP-dependent cortisol and dehydroepiandrosterone secretion, establishing
ASAH1
as a pivotal regulator of steroidogenic capacity in the human adrenal cortex.
...
PMID:Acid ceramidase (ASAH1) is a global regulator of steroidogenic capacity and adrenocortical gene expression. 2226 21